Taiwan FDA registration 074c45758c2ca34e8cbef89fe58cd9bb
Daisling Ryasan CMV immunoglobulin G detection reagent and quality control group
TW: 戴思林禮亞尚巨細胞病毒免疫球蛋白G檢測試劑及品管組
Taiwan·Risk Class 2·DIASORIN S.P.A.·Registered Nov 02, 2006 – Nov 02, 2016CancelledRegistration details
- Analysis ID
- 074c45758c2ca34e8cbef89fe58cd9bb
- Customs Code
- DHA00601758707
Company information
- Manufacturer
- DIASORIN S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- Chemically cold light immunoassay (CLIA) technology was used to quantify hCMV-specific immunoglobulin G antibodies in human serum or plasma samples.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3175 巨細胞病毒血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Nov 02, 2006
- Expiry Date
- Nov 02, 2016
- Cancellation Date
- May 28, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Daisling Ryasan CMV immunoglobulin G detection reagent and quality control group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 074c45758c2ca34e8cbef89fe58cd9bb and manufactured by DIASORIN S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices